News Website

In ovarian cancer, one drug target towers up to 100-fold above rivals - Stock Titan

In ovarian cancer, one drug target towers up to 100-fold above rivals Stock Titan

Published: April 10, 2026, 11 a.m.

Read Full Article

Epigenetic Compound Library Screen Identifies Ibrutinib as an Inhibitor of Ovarian Clear Cell Carcinoma Viability.

Ovarian clear cell carcinoma (OCCC) is an endometriosis-associated ovarian cancer subtype. Somatic mutations in OCCC are reported in ARID1A, PIK3CA, and the TERT promoter (TERTp), as well as less commonly …

Published: April 10, 2026, midnight

Read Full Article

Bruton's tyrosine kinase drug repurposing ibrutinib ovarian clear cell carcinoma

Proseek Bio raises AU$1.5m for ovarian cancer blood test - FemTech World

Proseek Bio raises AU$1.5m for ovarian cancer blood test FemTech World

Published: April 8, 2026, 11 a.m.

Read Full Article

Proseek Bio raises AU$1.5m for ovarian cancer blood test - femtechworld.co.uk

Proseek Bio raises AU$1.5m for ovarian cancer blood test femtechworld.co.uk

Published: April 8, 2026, 11 a.m.

Read Full Article

Brisbane startup raises $1.5m to commercialise its ovarian cancer detection blood test - Women's Agenda

Brisbane startup raises $1.5m to commercialise its ovarian cancer detection blood test Women's Agenda

Published: April 8, 2026, 1:50 a.m.

Read Full Article

SGO 2026 Preview: Endometrial and Ovarian Cancer - Medscape

SGO 2026 Preview: Endometrial and Ovarian Cancer Medscape

Published: March 30, 2026, 5:59 p.m.

Read Full Article

Young mum diagnosed with ovarian cancer warns women not to ignore signs - Kent Online

Young mum diagnosed with ovarian cancer warns women not to ignore signs Kent Online

Published: March 28, 2026, 4:33 p.m.

Read Full Article

Genetics of Endometriosis-Associated Ovarian Cancer: A Systematic Review.

Up to 1.6% of patients with endometriosis develop epithelial ovarian carcinoma. The genetic overlap between endometriosis and ovarian cancer has not been fully characterized. This review aims to describe the …

Published: March 26, 2026, midnight

Read Full Article

CTNNB1 clear cell ovarian carcinoma endometrioid ovarian carcinoma endometriosis endometriosis-associated ovarian cancer ovarian cancer

Global epidemiology of ovarian cancer: patterns, trends, and risk factors.

Ovarian cancer was the eighth most frequently diagnosed cancer among women in 2022. The global age-standardized incidence rate of ovarian cancer decreased from 7.22/100,000 to 6.71/100,000 from 1990 to 2021. …

Published: March 24, 2026, midnight

Read Full Article

Ovarian cancer epidemiology prevention risk factors screening trend

Hair Relaxer Endometrial Cancer Lawsuits and Ovarian Cancer Lawsuits Proposed for Early Trials - AboutLawsuits.com

Hair Relaxer Endometrial Cancer Lawsuits and Ovarian Cancer Lawsuits Proposed for Early Trials AboutLawsuits.com

Published: March 23, 2026, 4 p.m.

Read Full Article

Latest Articles

In ovarian cancer, one drug target towers up to 100-fold above rivals - Stock Titan

Epigenetic Compound Library Screen Identifies Ibrutinib as an Inhibitor of Ovarian Clear Cell Carcinoma Viability.

Proseek Bio raises AU$1.5m for ovarian cancer blood test - FemTech World

Proseek Bio raises AU$1.5m for ovarian cancer blood test - femtechworld.co.uk

Brisbane startup raises $1.5m to commercialise its ovarian cancer detection blood test - Women's Agenda

SGO 2026 Preview: Endometrial and Ovarian Cancer - Medscape

Young mum diagnosed with ovarian cancer warns women not to ignore signs - Kent Online

Genetics of Endometriosis-Associated Ovarian Cancer: A Systematic Review.

Global epidemiology of ovarian cancer: patterns, trends, and risk factors.

Hair Relaxer Endometrial Cancer Lawsuits and Ovarian Cancer Lawsuits Proposed for Early Trials - AboutLawsuits.com

Subscribe to Our Newsletter